AssayMetrics Ltd, a Cardiff, Wales, UK-based provider of a fluorescence plate reader used in drug screening, has raised an undisclosed sum in a second round equity investment from Finance Wales.
After launching its reader earlier in 2011, AssayMetrics has attracted significant interest from a number of global pharmaceutical companies and research groups and intends to use the funds to expand its sales and marketing efforts in the UK, Europe and the US.
The company, which received its first investment from Finance Wales in 2010 (read here), currently offers novel fluorescence technologies including dye labeling reagents, enzyme substrates, imaging agents and fluorescence lifetime platereaders.
AssayMetrics was founded in 2004 by flourescence expert Dr Pierre Graves (CEO).
FinSMEs
18/08/2011